Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Completed · Phase 2
Conditions studied: Substance-Related Disorders
In brief
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
Key facts
- Study ID
- NCT00000246
- Run by
- Yale University
- People needed
- 10
- Starts
- 1993-01-01
- Expected to finish
- 1994-12-01
- Last updated by the study team
- 2016-09-08
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Yale University, Psychiatry — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.